Related Experiment Video
Updated: Jul 30, 2026
05:46
A Proinflammatory, Degenerative Organ Culture Model to Simulate Early-Stage Intervertebral Disc Disease.
Published on: February 14, 2021
Gene therapy for degenerative disc disease.
S Sobajima1, J S Kim, L G Gilbertson
1Ferguson Laboratory, Department of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Gene Therapy
|January 16, 2004
Summary
Gene therapy offers a promising new approach to treat degenerative disc disease (DDD) by targeting the underlying cellular processes. Successful gene transfer in animal models paves the way for potential human clinical trials.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Molecular Biology
Background:
- Degenerative disc disease (DDD) leads to chronic pain and disability.
- Current treatments for DDD are invasive and have limitations.
- Aggrecan decline in the nucleus pulposus is a key feature of DDD.
Purpose of the Study:
- To review the potential of gene therapy for treating DDD.
- To explore methods for altering biological processes in degenerated intervertebral discs.
- To outline future research needed for human clinical trials.
Main Methods:
- Gene transfer to intervertebral disc cells in animal models.
- Modulating extracellular matrix synthesis and catabolism.
- Reviewing current advancements in gene therapy for DDD.
Main Results:
- Successful in vivo gene transfer to intervertebral disc cells demonstrated.
- Gene therapy shows potential to alter biological processes in degenerated discs.
- Progress made towards developing gene therapy for DDD treatment.
Conclusions:
- Gene therapy represents a novel, less invasive treatment strategy for DDD.
- Further research is required to translate these findings into human clinical applications.
- Targeting extracellular matrix components via gene therapy holds significant therapeutic promise.
Related Concept Videos
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
01:29Herniated Intervertebral Disc l: Introduction
Intervertebral disc herniation refers to the displacement of the nucleus pulposus (the gel-like inner core of the disc) through a tear or weakened area in the annulus fibrosus (the outer fibrous ring). The displaced disc material extends beyond the normal boundaries of the disc space and may compress or irritate nearby spinal nerve roots or, less commonly, the spinal cord.Etiology and Risk FactorsHerniation commonly results from degeneration, in which aging reduces disc hydration and...
01:27Degenerative Disc Disease I: Introduction
Degenerative disc disease is a chronic condition in which intervertebral discs gradually lose structure and function. It is not infectious or autoimmune; rather, it results from age-related biochemical and mechanical changes, influenced by genetic, metabolic, and environmental factors.Structure and Function of DiscsThe spine contains 23 intervertebral discs that absorb load, distribute forces, maintain spacing, and allow flexibility. Each disc consists of a nucleus pulposus, a gel-like core...
01:23Degenerative Disc Disease ll: Pathophysiology
The symptoms of degenerative disc disease arise from a combination of mechanical compression, vascular compromise, and biochemical inflammation, which together disrupt nerve function and produce pain.Mechanical CompressionDisc degeneration reduces height and elasticity, predisposing to herniation of the nucleus pulposus, a major cause of radicular pain. Herniations may be protrusion (bulging with intact annulus), extrusion (nucleus extends beyond disc but remains connected), or sequestration...